Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studying of New Signaling Pathway Targeting Systemic Lupus Erythematosus

NCT03984227 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03984227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03984227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studying of New Signaling Pathway Targeting Systemic Lupus Erythematosus
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2019
Completion date
April 30, 2021
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sle